Breast cancer type 1 susceptibility protein (P38398)

Uniprot ID P38398
Protein Name Breast cancer type 1 susceptibility protein
Gene Name BRCA1
Species Homo sapiens (Human)
Signal peptide(a) N Secretome P(b) 0.543
Function E3 ubiquitin-protein ligase that specifically mediates the formation of 'Lys-6'-linked polyubiquitin chains and plays a central role in DNA repair by facilitating cellular responses to DNA damage. It is unclear whether it also mediates the formation of other types of polyubiquitin chains. The E3 ubiquitin-protein ligase activity is required for its tumor suppressor function. The BRCA1-BARD1 heterodimer coordinates a diverse range of cellular pathways such as DNA damage repair, ubiquitination and transcriptional regulation to maintain genomic stability. Regulates centrosomal microtubule nucleation. Required for normal cell cycle progression from G2 to mitosis. Required for appropriate cell cycle arrests after ionizing irradiation in both the S-phase and the G2 phase of the cell cycle. Involved in transcriptional regulation of P21 in response to DNA damage. Required for FANCD2 targeting to sites of DNA damage. May function as a transcriptional regulator. Inhibits lipid synthesis by binding to inactive phosphorylated ACACA and preventing its dephosphorylation. Contributes to homologous recombination repair (HRR) via its direct interaction with PALB2, fine-tunes recombinational repair partly through its modulatory role in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at DNA breaks. Component of the BRCA1-RBBP8 complex which regulates CHEK1 activation and controls cell cycle G2/M checkpoints on DNA damage via BRCA1-mediated ubiquitination of RBBP8. Acts as a transcriptional activator (PubMed:20160719). .
GO - Molecular function
  • androgen receptor binding : NAS:UniProtKB
  • damaged DNA binding : IEA:Ensembl
  • DNA binding : TAS:ProtInc
  • enzyme binding : IPI:UniProtKB
  • identical protein binding : IPI:IntAct
  • RNA binding : IDA:MGI
  • RNA polymerase binding : IDA:UniProtKB
  • transcription coactivator activity : IMP:UniProtKB
  • transcription regulatory region DNA binding : IDA:BHF-UCL
  • tubulin binding : NAS:UniProtKB
  • ubiquitin protein ligase binding : IPI:UniProtKB
  • ubiquitin-protein transferase activity : IDA:UniProtKB
  • zinc ion binding : TAS:ProtInc
GO - Biological process
  • androgen receptor signaling pathway : NAS:UniProtKB
  • apoptotic process : TAS:UniProtKB
  • cellular response to DNA damage stimulus : TAS:ProtInc
  • cellular response to indole-3-methanol : IDA:UniProtKB
  • cellular response to tumor necrosis factor : IMP:BHF-UCL
  • centrosome cycle : IEA:Ensembl
  • chordate embryonic development : IBA:GO_Central
  • chromosome segregation : IMP:UniProtKB
  • DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator : TAS:UniProtKB
  • DNA double-strand break processing : TAS:Reactome
  • DNA replication : TAS:Reactome
  • dosage compensation by inactivation of X chromosome : IBA:GO_Central
  • double-strand break repair : IDA:CACAO
  • double-strand break repair via homologous recombination : IDA:HGNC-UCL
  • double-strand break repair via nonhomologous end joining : TAS:Reactome
  • fatty acid biosynthetic process : IEA:UniProtKB-KW
  • intrinsic apoptotic signaling pathway in response to DNA damage : IDA:MGI
  • mitotic G2/M transition checkpoint : IEA:Ensembl
  • negative regulation of centriole replication : NAS:UniProtKB
  • negative regulation of extrinsic apoptotic signaling pathway via death domain receptors : IMP:BHF-UCL
  • negative regulation of fatty acid biosynthetic process : IMP:UniProtKB
  • negative regulation of G0 to G1 transition : TAS:Reactome
  • negative regulation of histone acetylation : IBA:GO_Central
  • negative regulation of histone H3-K4 methylation : IEA:Ensembl
  • negative regulation of histone H3-K9 methylation : IDA:BHF-UCL
  • negative regulation of intracellular estrogen receptor signaling pathway : IMP:CACAO
  • negative regulation of reactive oxygen species metabolic process : IMP:BHF-UCL
  • negative regulation of transcription, DNA-templated : IDA:UniProtKB
  • positive regulation of angiogenesis : IMP:BHF-UCL
  • positive regulation of cell cycle arrest : IDA:BHF-UCL
  • positive regulation of DNA repair : IMP:UniProtKB
  • positive regulation of gene expression : IMP:BHF-UCL
  • positive regulation of histone acetylation : IDA:BHF-UCL
  • positive regulation of histone H3-K4 methylation : IDA:BHF-UCL
  • positive regulation of histone H3-K9 acetylation : IDA:BHF-UCL
  • positive regulation of histone H3-K9 methylation : IEA:Ensembl
  • positive regulation of histone H4-K16 acetylation : IDA:BHF-UCL
  • positive regulation of histone H4-K20 methylation : IDA:BHF-UCL
  • positive regulation of protein ubiquitination : IDA:UniProtKB
  • positive regulation of transcription by RNA polymerase II : IDA:UniProtKB
  • positive regulation of transcription, DNA-templated : IDA:UniProtKB
  • positive regulation of vascular endothelial growth factor production : IMP:BHF-UCL
  • postreplication repair : IDA:HGNC-UCL
  • protein autoubiquitination : IDA:UniProtKB
  • protein deubiquitination : TAS:Reactome
  • protein K6-linked ubiquitination : IDA:UniProtKB
  • protein ubiquitination : IDA:HGNC-UCL
  • regulation of apoptotic process : TAS:UniProtKB
  • regulation of cell population proliferation : TAS:UniProtKB
  • regulation of DNA methylation : IEA:Ensembl
  • regulation of gene expression by genetic imprinting : IEA:Ensembl
  • regulation of signal transduction by p53 class mediator : TAS:Reactome
  • regulation of transcription by RNA polymerase II : IMP:UniProtKB
  • regulation of transcription by RNA polymerase III : TAS:UniProtKB
  • response to estrogen : IDA:UniProtKB
  • response to ionizing radiation : IMP:UniProtKB
  • signal transduction involved in G2 DNA damage checkpoint : IMP:UniProtKB
Back
(a) The Signal peptide D-score cutoff for "YES"(having signal peptide) is 0.45.
(b) Non-classically secreted proteins should obtain an NN-score(Neural Networks score) exceeding the normal threshold of 0.5, but not at the same time be predicted to contain a signal peptide.